Total synthesis of the epidermal growth factor inhibitor (-)-reveromycin B

J Org Chem. 2001 Apr 6;66(7):2382-93. doi: 10.1021/jo001646c.

Abstract

The total synthesis of the epidermal growth factor inhibitor reveromycin B (2) in 25 linear steps from chiral methylene pyran 13 is described. The key steps involved an inverse electron demand hetero-Diels-Alder reaction between dienophile 13 and diene 12 to construct the 6,6-spiroketal 11 which upon oxidation with dimethyldioxirane and acid catalyzed rearrangement gave the 5,6-spiroketal aldehyde 9. Lithium acetylide addition followed by oxidation/reduction and protective group manipulation provided the reveromycin B spiroketal core 8 which was converted into the reveromycin A (1) derivative 6 in order to confirm the stereochemistry of the spiroketal segment. Introduction of the C1-C10 side chain began with sequential Wittig reactions to form the C8-C9 and C7-C6 bonds, and a tin mediated asymmetric aldol reaction installed the C4 and C5 stereocenters. The final key steps to the target molecule 2 involved a Stille coupling to introduce the C21-C22 bond, succinoylation, selective deprotection, oxidation, and Wittig condensation to form the final C2-C3 bond. Deprotection was effected by TBAF in DMF to afford reveromycin B (2) in 72% yield.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibiotics, Antineoplastic / chemical synthesis*
  • Antibiotics, Antineoplastic / pharmacology
  • Epidermal Growth Factor / antagonists & inhibitors
  • Pyrans / chemical synthesis*
  • Pyrans / pharmacology
  • Spiro Compounds / chemical synthesis*
  • Spiro Compounds / pharmacology
  • Stereoisomerism

Substances

  • Antibiotics, Antineoplastic
  • Pyrans
  • Spiro Compounds
  • reveromycin B
  • Epidermal Growth Factor